• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
RYTM

RYTM

Rhythm Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyUS

USD84.35

-3.52 (-4.01%)

Rating:D+

Company Profile

CEO

David Meeker

IPO Date

2017-10-09

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$86.38

Prev. Close

$87.87

Day Low

$82.89

Day High

$86.64

52W Low

$60.70

52W High

$122.20

Market Cap

$5.79B

Volume

0.52M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Insider Trades
FiledInsiderRoleTypeA/DSharesPrice
20 May 2026Smith Hunter CChief Financial OfficerM-ExemptAcquired3,000$17.87
20 May 2026Smith Hunter CChief Financial OfficerM-ExemptDisposed
3,000
$17.87
19 May 2026German Christopher PaulCorporate Controller & CAOM-ExemptAcquired1,687$56.69
19 May 2026German Christopher PaulCorporate Controller & CAOM-ExemptAcquired1,349$49.23
19 May 2026German Christopher PaulCorporate Controller & CAOM-ExemptAcquired1,406$17.97
19 May 2026German Christopher PaulCorporate Controller & CAOS-SaleDisposed4,643$92.21
19 May 2026German Christopher PaulCorporate Controller & CAOM-ExemptDisposed1,687$56.69
19 May 2026German Christopher PaulCorporate Controller & CAOM-ExemptDisposed1,349$49.23
19 May 2026German Christopher PaulCorporate Controller & CAOM-ExemptDisposed1,406$17.97
3 Apr 2026Mazabraud YannEVP, Head of InternationalM-ExemptAcquired12,875$0.00